The Alzheimer's Drug Discovery Foundation (ADDF) invites scientists from the biotechnology industry and academia to apply for a research grant through the Novel Approaches to Drug Discovery for Alzheimer's Disease award program. The goal of the program is to accelerate the discovery, development and clinical evaluation of effective therapies for Alzheimer's disease.
read more
The Alzheimer's Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $294,000 to Madera Biosciences, Inc. to develop small molecule drugs designed to clear accumulated beta-amyloid from the brain and thus halt o... Read Post
The Alzheimer's Drug Discovery Foundation (ADDF) announced that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation. The award will fund a drug discovery project to i... Read Post
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a grant of $100,000 to Edunn Biotechnology, Inc., an early stage company dedicated to developing a novel class of drugs to treat and prevent Alzhe... Read Post